Anzeige
❌
Mehr »
Sonntag, 01.11.2026 - Börsentäglich über 12.000 News
Gigantische Erzvorkommen im Pazifik: Ein kleiner Player wagt den Vorstoß
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
432 Leser
Artikel bewerten:
(1)

AI/ML Innovations Inc.: AI/ML Introduces Health Gauge's Advisory Board Members

TORONTO, ON / ACCESSWIRE / February 2, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company focused on acquiring and furthering Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to introduce the following members of the Advisory Board for its subsidiary, Health Gauge:

Dr. Pierre Boulanger, P.Eng , PhD, University of Alberta

Dr. Boulanger is a Professor and Cisco Chair in Healthcare, at the University of Alberta. He holds a double appointment of Professor at the University of Alberta's Department of Computing Science (where he is the Director of the Advanced Man-Machine Interface Laboratory) and the Department of Radiology and Diagnostic Imaging. He is also on the editorial board of two major academic journals and sits on several international academic committees. His scientific research topics include new techniques for tele-medicine; patient specific modeling using sensor fusion; the application of tele-presence technologies applied to aged care facilities and remote regions; the application of AR/VR technologies to medical training, simulation, and collaborative diagnostics; and patient-specific modeling in surgery. Dr. Boulanger has accumulated more than 38 years of experience in 3D computer vision, rapid product development, and the applications of virtual reality systems in medical and industrial manufacturing.

Dr. Jacques Kpodonu, MD, FACC

Dr. Kpodonu is a triple US boarded cardiac and endovascular surgeon based at the Beth Israel Deaconess Medical Center and surgical faculty at Harvard Medical School. Additionally, he is a visionary clinician, medical scientist, and the lead author and editor of four medical textbooks as well as having regularly published work on topics including digital health, biomedical innovation, design of hybrid operating rooms and recently addressing health equity during the COVID19 pandemic. Dr. Kpodonu holds leadership roles with the Society of Thoracic Surgery, American College of Cardiology, REACH program and is frequently quoted in national and international journals and media like the Orange County Register and CTSNET. Dr. Kpodonu's areas of professional expertise and interest include digital health technology, biomedical innovation, innovations in cardiac surgery, global health innovation, and precision medicine.

"The fact that Health Gauge has been able to attract internationally renowned medical and technology experts, such as Dr. Boulanger and Dr. Kpodonu, to its Advisory Board is a testament to both Health Gauge's best-in-class, wearable health solution, as well as to its visionary founders" said Tim Daniels, Chairman of AI/ML Innovations Inc. "Undoubtedly Drs. Boulanger and Kpodonu have much to contribute to the future successes of Health Gauge as they are uniquely qualified, with vast expertise in both the field of medicine and the application of leading technologies towards enhancing the quality of life by improving healthcare outcomes."

On behalf of the Board of Directors, Tim Daniels

For more information about AI/ML Innovations:

For detailed information please see AI/ML's website at https://aiml-innovations.com/ or the Company's filed documents at www.sedar.com.

Presentations:

Investor slidedeck: https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf
Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be

Contact:

For further information, contact Blake Fallis at (250) 384-1999 or info@aiml-innovations.com.

About AI/ML Innovations Inc.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML".

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: AI/ML Innovations Inc.



View source version on accesswire.com:
https://www.accesswire.com/627251/AIML-Introduces-Health-Gauges-Advisory-Board-Members

© 2021 ACCESS Newswire
Historische Öl-Krise - 5 Aktien, die davon profitieren!
Der Iran-Krieg hat den globalen Energiemarkt erschüttert. Zerstörte Förderanlagen, ausgefallene Transportwege und fehlende Raffineriekapazitäten sorgen dafür, dass nicht nur Rohöl, sondern vor allem Benzin und Diesel knapp und teuer bleiben könnten. Selbst ein Ende der Kämpfe würde das Problem nicht über Nacht lösen, der Wiederaufbau der Energieinfrastruktur dürfte Jahre dauern.

Während viele Anleger jetzt auf ExxonMobil, Chevron oder Shell setzen, könnte das größere Potenzial längst woanders liegen. Denn hohe Ölpreise machen neue Investitionen in Förderung, Transport und Verarbeitung wieder attraktiv. Davon profitieren vor allem jene Unternehmen, die Bohrtechnik, Ausrüstung und Dienstleistungen bereitstellen oder bereits über wertvolle Infrastruktur verfügen.

Hier dürfte die zweite Welle des Öl-Booms entstehen. Statt den bereits stark gelaufenen Produzenten hinterherzulaufen, können Anleger auf die Unternehmen setzen, die am milliardenschweren Wiederaufbau der globalen Energieinfrastruktur verdienen.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, die von der historischen Öl-Krise besonders profitieren könnten.

Jetzt den kostenlosen Report sichern und die möglichen Gewinner der zweiten Öl-Welle entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.